Biocodex is a French family-owned pharmaceutical group and corporate strategic investor headquartered in Gentilly, France. It invests in start-ups through R&D and scientific partnerships, with strategic focus on microbiome, women’s health, mental health, rare diseases and broader life sciences and pharmaceutical innovation. Its venture activity is most relevant to later-stage healthtech, biotechnology, life sciences, pharmaceuticals and women’s health companies seeking strategic corporate capital in France or globally.